On Friday, Pulmonx Corp (NASDAQ: LUNG) was 6.08% up from the session before settling in for the closing price of $1.81. A 52-week range for LUNG has been $1.47 – $9.37.
Annual sales at Healthcare sector company slipped by -19.80% over the past five years. When this article was written, the company’s average yearly earnings per share was at -7.80%. With a float of $36.05 million, this company’s outstanding shares have now reached $40.74 million.
Pulmonx Corp (LUNG) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Pulmonx Corp stocks. The insider ownership of Pulmonx Corp is 11.54%, while institutional ownership is 82.09%. The most recent insider transaction that took place on Sep 02 ’25, was worth 15,437. In this transaction PRESIDENT AND CEO of this company sold 9,648 shares at a rate of $1.60, taking the stock ownership to the 358,967 shares. Before that another transaction happened on Sep 02 ’25, when Company’s Chief Financial Officer & PAO sold 7,936 for $1.60, making the entire transaction worth $12,698. This insider now owns 208,489 shares in total.
Pulmonx Corp (LUNG) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.36 earnings per share (EPS) during the time that was better than consensus figure (set at -0.44) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.50% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
You can see what Pulmonx Corp (LUNG) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.43, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.44 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Pulmonx Corp (NASDAQ: LUNG) saw its 5-day average volume 1.19 million, a positive change from its year-to-date volume of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 17.24%.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 18.67%, which indicates a significant decrease from 27.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2170 in the past 14 days, which was higher than the 0.1754 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7010, while its 200-day Moving Average is $3.7996. Nevertheless, the first resistance level for the watch stands at $1.9822 in the near term. At $2.0443, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.1537. If the price goes on to break the first support level at $1.8107, it is likely to go to the next support level at $1.7013. Assuming the price breaks the second support level, the third support level stands at $1.6392.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
There are 40,747K outstanding shares of the company, which has a market capitalization of 78.23 million. As of now, sales total 83,790 K while income totals -56,390 K. Its latest quarter income was 23,860 K while its last quarter net income were -15,170 K.
